期刊
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 67, 期 5, 页码 1211-1216出版社
OXFORD UNIV PRESS
DOI: 10.1093/jac/dks011
关键词
HIV; non-nucleoside reverse transcriptase inhibitors; therapeutic drug monitoring
Plasma concentrations are frequently used for therapeutic drug monitoring of antiretroviral drugs. Dried blood spot sampling offers a patient-friendly and easy alternative to plasma sampling. However, dried blood spot concentrations are not necessarily equal to plasma concentrations and therefore the objective of this work was to establish the relationship between nevirapine and efavirenz dried blood spot and plasma concentrations to facilitate clinical implementation of dried blood spot sampling. Paired dried blood spot and plasma samples were obtained from 40 HIV-infected patients on nevirapine and 40 on efavirenz treatment. All samples were analysed using validated HPLCtandem mass spectrometry methods for the two matrices. Theoretical plasma concentrations were calculated from dried blood spot concentrations using the formula [dried blood spot concentration/(1haematocrit)]fraction bound to plasma proteinsplasma concentration. Linear regression and BlandAltman analysis were used to compare the two methods. Dried blood spot and plasma concentrations of nevirapine and efavirenz correlated well (r(2)0.867 and 0.972, respectively), although efavirenz dried blood spot concentrations were 39.8 (SD 7.1) lower than plasma concentrations. Theoretical plasma concentrations (using patient-specific haematocrit) of nevirapine and efavirenz were similar to measured plasma concentrations, with a mean difference between the two methods of 0.29 mg/L (SD 1.35 mg/L) and 0.08 mg/L (SD 0.31 mg/L), respectively. Dried blood spot concentrations of nevirapine and efavirenz were equal to plasma concentrations after correction for haematocrit and compound-specific plasma protein binding and can therefore be used in clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据